Role of SMAD proteins in colitis-associated cancer: from known to the unknown

P Chandrasinghe1,2,3, B Cereser1, M Moorghen2

  • 1Department of Surgery and Cancer, Imperial College London, London, UK.

Oncogene
|September 5, 2017
PubMed

Insights

Small mothers against decapentaplegic (SMAD) proteins are crucial in inflammatory bowel disease (IBD) and colitis-associated colorectal cancer (CAC). Research is exploring SMADs

Area of Science:

  • Molecular biology
  • Gastroenterology
  • Oncology

Background:

  • Small mothers against decapentaplegic (SMAD) proteins are key signal transducers in transforming growth factor β (TGFβ) pathways.
  • Chronic inflammatory bowel disease (IBD) increases the risk of colitis-associated colorectal cancer (CAC).
  • SMAD proteins and TGFβ superfamily ligands are implicated in colorectal cancer development.

Purpose of the Study:

  • To review the evidence linking SMAD proteins to colitis-associated colorectal cancer (CAC).
  • To explore the role of SMAD proteins in CAC pathogenesis.
  • To identify future research directions regarding SMADs in CAC.

Main Methods:

  • Literature review of existing studies on SMAD proteins, IBD, and CAC.
  • Analysis of the molecular mechanisms by which SMADs influence carcinogenesis.
  • Synthesis of current knowledge on therapeutic modulation of SMADs in IBD and its implications for cancer.

Main Results:

  • SMAD proteins are involved in critical carcinogenic processes, including gene transcription alteration, stem cell differentiation control, and epigenetic modifications.
  • The precise impact of therapeutic modulation of SMADs for IBD on CAC development is not yet fully understood.
  • Evidence suggests a significant role for SMADs in the unique characteristics of CAC.

Conclusions:

  • SMAD proteins are central to both IBD pathogenesis and the development of CAC.
  • Further research is needed to elucidate the dual role of SMADs and to guide therapeutic strategies.
  • Understanding SMADs' function in CAC is crucial for developing effective treatments for IBD patients at risk of cancer.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.7K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
10.8K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.4K